Santa Cruz Biotechnology provides a broad selection of ICADL Antibodies for research applications. ICADL Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ICADL, or Inhibitor of Caspase-Activated DNase-Like, plays a crucial role in regulating apoptosis and maintaining cellular integrity. By inhibiting the activity of caspase-activated DNase, ICADL helps prevent unwanted DNA fragmentation during programmed cell death, making it essential for normal cellular function and development. Understanding ICADL's role in various biological processes can provide insights into disease mechanisms and potential therapeutic targets. ICADL monoclonal antibodies enable precise detection and quantification in diverse experimental settings. Researchers can explore cellular pathways involved in programmed cell death and DNA fragmentation with reliable results. ICADL monoclonal antibodies from Santa Cruz Biotechnology support scientists worldwide in advancing our understanding of cellular processes and potential therapeutic applications.